Compare SYY & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYY | CNC |
|---|---|---|
| Founded | 1969 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.9B | 34.0B |
| IPO Year | 2004 | 2001 |
| Metric | SYY | CNC |
|---|---|---|
| Price | $83.68 | $71.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 21 |
| Target Price | ★ $91.08 | $71.78 |
| AVG Volume (30 Days) | ★ 3.3M | 3.0M |
| Earning Date | 11-03-2026 | 10-27-2026 |
| Dividend Yield | ★ 2.68% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 3.66 | ★ 5.30 |
| Revenue | $84,553,000,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $6.48 | $11.28 |
| Revenue Next Year | $2.27 | N/A |
| P/E Ratio | $22.45 | ★ $13.26 |
| Revenue Growth | 3.91 | ★ 19.44 |
| 52 Week Low | $68.19 | $31.63 |
| 52 Week High | $91.85 | $71.71 |
| Indicator | SYY | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 65.33 | 65.83 |
| Support Level | $82.33 | $63.36 |
| Resistance Level | $85.05 | N/A |
| Average True Range (ATR) | 1.32 | 2.17 |
| MACD | 0.68 | 0.61 |
| Stochastic Oscillator | 98.72 | 87.57 |
Sysco is the largest foodservice distributor in the US, with an 18% share of the $377 billion vertical. The firm sells and distributes over 500,000 food and nonfood products to about 730,000 customer locations, primarily serving restaurants, which represented 60% of fiscal 2025 sales. The balance of sales stems from healthcare facilities (8%), education and government customers (8%), travel and leisure clients (7%), and other smaller end markets (17%), like cafeterias. By segment, Sysco earns the bulk of its revenue from its US foodservice operations (70%), followed by its international footprint (18%), SYGMA, which focuses on quick-service logistics (10%), and other (2%). The pending Jetro Restaurant Depot deal stands to add $16 billion in sales upon close, expected in fiscal 2027.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.